Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety
about
Chinese herbal medicines for hypercholesterolemiaThe ethics of traditional chinese and Western herbal medicine research: views of researchers and human ethics committees in australia.The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells.Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers.Paediatric homoeopathy in general practice: where, when and why?Homoeopathic and herbal prescribing in general practice in Scotland.Natural health product interactions with medication.Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.Natural health product-drug interaction tool: A scoping review.Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitroComplementary and alternative medicine use among diabetic patients in Africa: a Kenyan perspective.Tracking and treating activated T cells.Concomitant intake of quercetin with a grain-based diet acutely lowers postprandial plasma glucose and lipid concentrations in pigs.Ethical Considerations for Acupuncture and Chinese Herbal Medicine Clinical Trials: A Cross-cultural Perspective.PHARMACEUTICAL EVALUATION AND TOXICOLOGICAL QUANTIFICATION OF HEAVY METALS AND ADULTERATED ALLOPATHIC CONTENTS IN RAW AND FINISHED DOSAGE FORM OF ANTIHYPERTENSIVE HERBAL PRODUCTS.Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor- and cell-mediated responses.Prevalence and correlates of herbal medicine use among type 2 diabetic patients in Teaching Hospital in Ethiopia: a cross-sectional study.Induction of cytochrome P450s by terpene trilactones and flavonoids of theGinkgo bilobaextract EGb 761 in rats
P2860
Q24235695-B74D1486-9507-474E-9EAD-389CB0A19499Q34416859-F2E5CB29-0624-4292-9ADE-F94A0D92A168Q34432298-245EEE51-8940-4634-BF56-8919729A7399Q34551642-D0C36306-A78B-435B-8A0B-D77E0C9019CAQ35645820-DFC78583-8A86-48C3-BA7E-283B6CFDCD87Q35827040-5AD36D12-16B1-4D53-8447-BB9E747FACAEQ35827924-BDFAE731-D4E1-4D47-B16A-D9BD07837DBBQ36278312-F8911BD6-0F51-4245-8AD8-84A4FF8307D5Q36377254-52E3A191-2100-481C-BDA9-780114F95758Q36744650-83053136-3E82-4E12-A57E-75DB83869006Q37143220-CDB42D97-2042-483A-8B10-E14B64F4557AQ37308503-3A40192F-B662-4BBF-A12E-A4DE03CFA009Q38198637-33073AAE-C99A-45BE-88CE-10E5B54B30ACQ39196470-4F76F214-B200-4B9B-9337-28BA383BCB48Q41138025-B0CD2558-5CEB-4D98-8BD6-B7F726506D6CQ41662487-0B9B39D7-D8C7-438C-B711-37032399D0EEQ50603550-AED57E01-C544-41FC-AC60-0D45FE1F3802Q55011240-66E45F07-5542-42D4-ACAA-4EC97FEE7A67Q56031652-70422682-01F4-4AD1-9203-11FB4E70D860
P2860
Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@ast
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@en
type
label
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@ast
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@en
prefLabel
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@ast
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@en
P2860
P1476
Quality, efficacy and safety o ...... . Part II: Efficacy and safety
@en
P2860
P304
P356
10.1046/J.1365-2125.2003.01811.X
P407
P577
2003-04-01T00:00:00Z